Tema Oncology ETF (CANC)
NasdaqGM: CANC
· Precio en tiempo real · USD
42.55
-0.59 (-1.37%)
Al cierre: Aug 13, 2026, 3:58 PM
Tema Oncology ETF (CANC) ETF Price, Holdings & Analysis
-1.37% (1D)
| Precio de compra | 41.61 |
| Capitalización de mercado | n/a |
| AUM | 193.31M |
| NAV | 42.91 |
| Beta | n/a |
| EPS (ttm) | n/a |
| Relación PE (ttm) | 26.76 |
| Acciones en circulación | n/a |
| Fecha de inicio | Aug 14, 2023 |
| Precio de venta | 42.11 |
| Volumen | 18,707 |
| Volumen medio (20D) | 32,104 |
| Abierto | 43.51 |
| Cierre anterior | 43.14 |
| Rango del día | 42.36 - 43.51 |
| Rango de 52 semanas | 26.24 - 43.51 |
| Participaciones | n/a |
| Relación de gastos | 0.75% |
Acerca de CANC
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Clase de activo Equity
Símbolo bursátil CANC
Fecha de inicio Aug 14, 2023
Proveedor Tema Etfs
Sitio web Página de inicio del fondo
Intercambio NasdaqGM
Las 10 principales participaciones 42.56% de activos
| Nombre | Símbolo | Peso |
|---|---|---|
| Revolution Medicines... | RVMD | 6.14% |
| Cogent Biosciences I... | COGT | 5.31% |
| Eli Lilly And Co | LLY | 5.22% |
| Roche Holding Ag Adr | RHHBY | 4.65% |
| Novartis Ag Register... | NOVN.SW | 4.16% |
| Bristol-myers Squibb... | BMY | 3.73% |
| Abbvie Inc | ABBV | 3.72% |
| Merck & Co Inc | MRK | 3.65% |
| Johnson & Johnson | JNJ | 3.13% |
| Immunome Inc Ordinar... | IMNM | 2.85% |
Dividendos Rendimiento de dividendos 0.05%
| Ex-Dividendo | Cantidad | Fecha de pago |
|---|---|---|
| Dec 10, 2025 | $0.0200 | n/a |
| Dec 11, 2024 | $0.7280 | n/a |
| Dec 13, 2023 | $0.1490 | n/a |
